iBio, Inc. SEC filings IBIO
iBio, Inc. has 909 filings in SEC EDGAR's recent list, going back to Mar 7, 2008. Its latest annual report, Form ARS, was filed on Sep 4, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 6, 2026 | — |
| CORRESP | Letter to the SEC | Mar 4, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2026 | — |
| EFFECT | Filing | Feb 9, 2026 | — |
| CORRESP | Letter to the SEC | Feb 5, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2026 | — |
| D | Filing | Jan 22, 2026 | — |
| EFFECT | Filing | Jun 23, 2025 | — |
| CORRESP | Letter to the SEC | Jun 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2025 | — |
| D | Filing | May 7, 2025 | — |
| 25 | Form 25 | Mar 3, 2025 | — |
| CERT | Filing | Mar 3, 2025 | — |
| 8-A12B | Form 8-a12b | Mar 3, 2025 | — |
| EFFECT | Filing | Feb 10, 2025 | — |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2025 | — |
| EFFECT | Filing | Aug 6, 2024 | — |
| CORRESP | Letter to the SEC | Aug 2, 2024 | — |
| CORRESP | Letter to the SEC | Jul 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2024 | — |
| D | Filing | Apr 4, 2024 | — |
| EFFECT | Filing | Dec 4, 2023 | — |
| CORRESP | Letter to the SEC | Nov 30, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2023 | — |
| EFFECT | Filing | Oct 4, 2023 | — |
| D | Filing | Aug 15, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2023 | — |
| NT 10-K | Filing | Sep 29, 2022 | Jun 30, 2022 |
| DEFR14A | Filing | Jun 14, 2022 | — |
| EFFECT | Filing | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2020 | — |
| CORRESP | Letter to the SEC | Dec 3, 2020 | — |
| NT 10-K | Filing | Sep 28, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Mar 19, 2020 | — |
| CORRESP | Letter to the SEC | Mar 19, 2020 | — |
| CORRESP | Letter to the SEC | Mar 13, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2020 | — |
| EFFECT | Filing | Oct 24, 2019 | — |
| CORRESP | Letter to the SEC | Oct 24, 2019 | — |
| CORRESP | Letter to the SEC | Oct 24, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2019 | — |
| SC TO-I/A | Filing | Mar 13, 2019 | — |
| SC TO-I | Filing | Jan 22, 2019 | — |
| SC TO-C | Filing | Dec 17, 2018 | — |
| SC TO-C | Filing | Dec 17, 2018 | — |
| EFFECT | Filing | Jun 21, 2018 | — |
| CORRESP | Letter to the SEC | Jun 20, 2018 | — |
| CORRESP | Letter to the SEC | Jun 20, 2018 | — |
| UPLOAD | Letter from the SEC | May 11, 2018 | — |
| EFFECT | Filing | Aug 11, 2017 | — |
| CORRESP | Letter to the SEC | Aug 10, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2017 | — |
| NT 10-Q | Filing | Feb 14, 2017 | Dec 31, 2016 |
| NT 10-Q | Form nt 10-q | Nov 14, 2016 | Sep 30, 2016 |
| NT 10-K | Form 12b-25 | Sep 28, 2016 | Jun 30, 2016 |
| NT 10-Q | Filing | May 16, 2016 | Mar 31, 2016 |
| NT 10-Q | Filing | Feb 17, 2016 | Dec 31, 2015 |
| D | Filing | Feb 3, 2016 | — |
| NT 10-K | Filing | Sep 28, 2015 | Jun 30, 2015 |
| NT 10-Q | Form nt 10-q | Feb 17, 2015 | Dec 31, 2014 |
| EFFECT | Filing | Dec 2, 2014 | — |
| EFFECT | Filing | Oct 17, 2014 | — |
| CT ORDER | Filing | Dec 13, 2013 | — |
| NT 10-Q | Filing | May 16, 2013 | Mar 31, 2013 |
| NT 10-Q | Filing | Feb 14, 2013 | Dec 31, 2012 |
| NT 10-K | Filing | Sep 28, 2012 | Jun 30, 2012 |
| NT 10-K | Filing | Sep 29, 2011 | Jun 30, 2011 |
| EFFECT | Filing | Jul 28, 2011 | — |
| CORRESP | Letter to the SEC | Jul 27, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2011 | — |
| NT 10-Q | Filing | May 17, 2011 | Mar 31, 2011 |
| EFFECT | Filing | Mar 18, 2011 | — |
| CORRESP | Letter to the SEC | Mar 17, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2011 | — |
| CORRESP | Letter to the SEC | Feb 16, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 7, 2011 | — |
| CERTNYS | Auto-generated paper document | Jan 3, 2011 | — |
| 8-A12B | Filing | Dec 29, 2010 | — |
| RW | Filing | Dec 17, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2010 | — |
| D | Filing | Nov 10, 2010 | — |
| CORRESP | Letter to the SEC | Nov 8, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2010 | — |
| NT 10-K | Filing | Sep 27, 2010 | Jun 30, 2010 |
| NT 10-Q | Filing | May 18, 2010 | Mar 31, 2010 |
| EFFECT | Filing | Oct 21, 2009 | — |
| D | Filing | Sep 23, 2009 | — |
| EFFECT | Filing | May 13, 2009 | — |
| REGDEX | Auto-generated paper document | Sep 2, 2008 | — |
| 10-12G/A | Filing | Aug 12, 2008 | — |
| 10-12G/A | Filing | Jul 17, 2008 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2008 | — |
| 10-12G | Filing | Jul 11, 2008 | — |
| RW | Filing | Jul 8, 2008 | — |
| 10-12G | Filing | Jun 18, 2008 | — |
| RW | Filing | Jun 17, 2008 | — |
| 10-12G | Filing | May 12, 2008 | — |
| 10-12G | Inb biotechnologies, inc. | Mar 7, 2008 | — |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBIO (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1420720
- Former names
- iBio, Inc. (until Oct 19, 2026); iBioPharma, Inc. (until Aug 14, 2009); InB:Biotechnologies, Inc. (until Jul 17, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.